Aspire Private Capital’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-300
Closed -$96.6K 185
2024
Q3
$96.6K Sell
300
-18
-6% -$5.89K 0.02% 194
2024
Q2
$99.4K Buy
318
+12
+4% +$3.52K 0.03% 194
2024
Q1
$87.1K Sell
306
-2
-0.6% -$585 0.02% 199
2023
Q4
$88.8K Sell
308
-37
-11% -$10.1K 0.03% 191
2023
Q3
$92.8K Buy
345
+9
+3% +$2.25K 0.03% 165
2023
Q2
$74.7K Buy
336
+39
+13% +$9.05K 0.02% 176
2023
Q1
$71.8K Buy
297
+22
+8% +$5.4K 0.02% 172
2022
Q4
$72.2K Sell
275
-2
-0.7% -$536 0.03% 164
2022
Q3
$62K Sell
277
-2
-0.7% -$485 0.02% 166
2022
Q2
$68K Buy
279
+1
+0.4% +$245 0.02% 166
2022
Q1
$67K Sell
278
-31
-10% -$7.12K 0.02% 177
2021
Q4
$70K Sell
309
-3
-1% -$633 0.02% 194
2021
Q3
$66K Sell
312
-19
-6% -$4.37K 0.02% 194
2021
Q2
$81K Sell
331
-259
-44% -$63.7K 0.03% 184
2021
Q1
$147K Sell
590
-759
-56% -$181K 0.05% 163
2020
Q4
$310K Sell
1,349
-7
-0.5% -$1.61K 0.12% 90
2020
Q3
$345K Buy
1,356
+141
+12% +$34.9K 0.14% 85
2020
Q2
$287K Buy
1,215
+186
+18% +$42.4K 0.13% 81
2020
Q1
$209K Sell
1,029
-417
-29% -$91.1K 0.11% 86
2019
Q4
$349K Buy
1,446
+765
+112% +$169K 0.15% 85
2019
Q3
$132K Buy
681
+50
+8% +$9.6K 0.06% 124
2019
Q2
$116K Buy
631
+77
+14% +$13.8K 0.06% 137
2019
Q1
$105K Sell
554
-97
-15% -$18.5K 0.05% 165
2018
Q4
$127K Buy
+651
New +$127K 0.07% 141

Other funds holding AMGN

Aspire Private Capital's AMGN Position: Q4 2024 in Review

Aspire Private Capital sold out of Amgen (AMGN) in Q4 2024, closing a stake of 300 shares — an estimated $96.6K sold.

Aspire Private Capital first reported a position in AMGN in Q4 2018 and held it in 24 quarters. The position peaked at $349K in Q4 2019. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Aspire Private Capital reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
  • Aspire Private Capital sold 300 Amgen shares in Q4 2024, an estimated $96.6K.
  • Aspire Private Capital first reported a position in Amgen in Q4 2018 and held it in 24 quarters.
  • Aspire Private Capital's Amgen position peaked at $349K in Q4 2019.
  • 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Aspire Private Capital's 13F filing for Q4 2024, filed 17 Jan 2025.